0002088831-25-000001.txt : 20250929 0002088831-25-000001.hdr.sgml : 20250929 20250926174712 ACCESSION NUMBER: 0002088831-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250929 DATE AS OF CHANGE: 20250926 EFFECTIVENESS DATE: 20250929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kayak Therapeutics, Inc. CENTRAL INDEX KEY: 0002088831 ORGANIZATION NAME: EIN: 393869900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-558986 FILM NUMBER: 251351654 BUSINESS ADDRESS: STREET 1: 3317 BOWMAN AVENUE CITY: AUSTIN STATE: TX ZIP: 78703 BUSINESS PHONE: 917.892.9996 MAIL ADDRESS: STREET 1: 3317 BOWMAN AVENUE CITY: AUSTIN STATE: TX ZIP: 78703 D 1 primary_doc.xml X0708 D LIVE 0002088831 Kayak Therapeutics, Inc. 3317 BOWMAN AVENUE AUSTIN TX TEXAS 78703 917.892.9996 DELAWARE None None Corporation true 2025 Tyler Brous 3317 Bowman Avenue Austin TX TEXAS 78703 Director Conor Richardson 3317 Bowman Avenue Austin TX TEXAS 78703 Executive Officer Hornblower Josiah 3317 Bowman Avenue Austin TX TEXAS 78703 Executive Officer Director Biotechnology Decline to Disclose 06b false 2025-09-11 false true false 0 10000000 6630000 3370000 false 42 0 0 0 false Kayak Therapeutics, Inc. Conor Richardson Conor Richardson Chief Financial Officer 2025-09-26